Roche Gets CDSCO Panel Nod to Study anti-cancer Drug Inavolisib
New Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the trial of anti-cancer drug Inavolisib. This came the drug major Roche presented Phase III Clinical Study Protocol no. WO44263. The study is to evaluate the efficacy and safety […]